Hologic's International Momentum Takes Shape: Will Execution Pay Off?

Key Takeaways HOLX now earns 25% of revenues internationally, with room to expand compared to peers.Hologic's International Surgical sales rose 16.2% in Q2, led by strong MyoSure and NovaSure performance.HOLX sees a global drag from Korea strikes, China headwinds and lower HIV testing in Africa.International expansion continues to play a central role in Hologic’s (HOLX) growth strategy. Currently, it generates around 25% of its total revenues from outside the United States — a lower proportion compared to o ...